KALA BIO's market cap is currently $5.28M. The company's EPS TTM is $-1.01; its P/E ratio is -0.11; KALA BIO is scheduled to report earnings on November 17, 2025, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.
